An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis

An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis

The main goals of Ulcerative Colitis (UC) treatment are to both induce and maintain the clinical and endoscopic remission of disease, reduce the incidence of complications such as dysplasia and colorectal carcinoma and improve quality of life. Although a curative medical treatment for UC has not yet...

Full description

Bibliographic Details
Main Authors:	Francesca Ferretti, Rosanna Cannatelli, Maria Camilla Monico, Giovanni Maconi, Sandro Ardizzone
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Journal of Clinical Medicine
Subjects:	5-aminosalicylic acid azathioprine biologic therapy corticosteroids inflammatory bowel disease small molecule
Online Access:	https://www.mdpi.com/2077-0383/11/9/2302

Similar Items

Therapeutic Management of Adults with Inflammatory Bowel Disease and Malignancies: A Clinical Challenge
by: Francesca Ferretti, et al.
Published: (2023-01-01)

Evaluation of low doses of Azathioprine in reducing relapse and corticosteroid dependence in patients with Ulcerative Colitis
by: Maryam Rezaiee, et al.
Published: (2019-05-01)

Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis
by: Kristine Paridaens, et al.
Published: (2023-07-01)

Acute granulomatous interstitial nephritis and ulcerative colitis: a case report and literature review
by: Giorgia Comai, et al.
Published: (2018-03-01)

Efficacy of mesalazine at ulcerative colitis with nutritional failure
by: A. V. Korolyov, et al.
Published: (2024-03-01)

Management and treatment of distal ulcerative colitis
by: Andrea Calafiore, et al.
Published: (2013-12-01)

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis
by: Hyo Yeop Song, et al.
Published: (2022-01-01)

Effectiveness of treatment of moderate ulcerative colitis with prolonged mesalazine in real clinical practice
by: O. V. Knyazev, et al.
Published: (2021-10-01)

Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
by: Yu. P. Uspenskiy, et al.
Published: (2022-03-01)

USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
by: M. V. Shapina, et al.
Published: (2017-11-01)

Treatment of Ulcerative Colitis: Impact on Platelet Aggregation
by: Sasa Peric, et al.
Published: (2023-09-01)

Retrospective analysis of immunosuppressive and anti‐thrombotic protocols in nonassociative immune mediated hemolytic anemia in dogs
by: Jennifer Weng, et al.
Published: (2023-03-01)

Pre-Treatment and Post-Treatment Demodex Densities in Patients under Immunosuppressive Treatments
by: Hacer Keles, et al.
Published: (2020-03-01)

Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials
by: AlAmeel T, et al.
Published: (2023-08-01)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
by: Yan Yan, et al.
Published: (2019-12-01)

Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial
by: Jan Březina, et al.
Published: (2021-06-01)

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
by: Virginia Solitano, et al.
Published: (2020-09-01)

Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT
by: Pierre-Olivier Harmand, et al.
Published: (2020-10-01)

Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial
by: Andreas Blesl, et al.
Published: (2023-07-01)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
by: Siriorn Sukanjanapong, et al.
Published: (2019-12-01)

Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
by: Wooseong Kim, et al.
Published: (2019-11-01)

Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice
by: Masataka Masuda, et al.
Published: (2022-09-01)

5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
by: Asuka Watanabe, et al.
Published: (2024-01-01)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
by: Oliwia Zakerska-Banaszak, et al.
Published: (2022-03-01)

Treatment of recalcitrant disseminated ulcerative necrobiosis lipoidica with ustekinumab
by: Patrick McMullan, PhD, et al.
Published: (2023-11-01)

A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
by: Yang Y, et al.
Published: (2018-12-01)

Evaluation of the mTORC activity in the presence of Toxoplasma gondii and azathioprine in human monocyte cell line
by: Sara Nemati, et al.
Published: (2023-03-01)

Development and validation of a novel HPLC-UV method for simultaneous determination of azathioprine metabolites in human red blood cells
by: Hengyi Yu, et al.
Published: (2023-03-01)

Medicinal Flavor of Fecal Microbiota and Efficacies of Its Transplantation in Mice with Different Types of Ulcerative Colitis
by: Xiaofei MA, Jiali HU, Manman CUI, Wei GE, Suqin YANG, Chenghua DING, Leichang ZHANG
Published: (2022-05-01)

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
by: Yamile Zabana, et al.
Published: (2022-12-01)

DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease
by: Davide Selvestrel, et al.
Published: (2023-01-01)

Clinical and Morphological Analysis of Efficacy of Intraperitoneal Ozone Application in Experimental Colitis: Preclinical Randomized Experimental Study
by: M. V. Osikov, et al.
Published: (2023-02-01)

Azathioprine: its uses in dermatology,
by: Sonia Chavez-Alvarez, et al.
Published: (2020-11-01)

Los polimorfismos de ITPA no predicen un riesgo adicional más allá de TPMT y NUDT15 para citopenia inducida por tiopurina en la enfermedad inflamatoria intestinal
by: A. Jena, et al.
Published: (2024-01-01)

The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review
by: Aline C. Ribeiro, et al.
Published: (2023-10-01)

Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
by: Rohan V Yewale, et al.
Published: (2023-09-01)

Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients
by: Nashwa Eltantawy, et al.
Published: (2023-01-01)

Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy
by: Napolitano M, et al.
Published: (2022-06-01)

The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study
by: Francesca Ferretti, et al.
Published: (2022-08-01)

Ulcerative Colitis and Neopterin: Related?
by: Beşir Kesici, et al.
Published: (2019-04-01)